-+ 0.00%
-+ 0.00%
-+ 0.00%

GSK: HEALTH CANADA EXPANDS JEMPERLI PLUS CHEMOTHERAPY APPROVAL TO ALL ADULT PATIENTS WITH PRIMARY ADVANCED OR FIRST RECURRENT ENDOMETRIAL CANCER

Reuters·04/17/2025 17:16:49

Please log in to view news